With Innovent Biologics garnering buzz in the dealmaking space, Ta | Takeda and Innovent's long-term follow-up data from an ...
In this week's Tour Report, Cameron Young makes his move to the Titleist GTS3 driver, Justin Rose plays a raw set of McLarens ...
Phase 4 ELEVATE-PD interim data from the entire study population (n=214) continue to show clinically meaningful, consistent benefits of CREXONT ...
Ivonescimab plus chemotherapy helped patients with advanced squamous NSCLC live longer than tislelizumab plus chemotherapy. Patients with previously untreated advanced squamous non-small cell lung ...
A first-in-class bispecific antibody-drug conjugate that Bristol Myers Squibb paid $800 million for has shown strong phase 3 ...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran ...
WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next ...
CHICAGO -- An investigational individualized vaccine for surgically resected melanoma demonstrated durable benefits in reducing the risks of recurrence and distant spread, 5-year follow-up of a ...
GLP-1 RA use was also tied to lower rates of immune-related side effects, caused by the immune system becoming overactive as a result of immunotherapy treatment. Patients taking GLP-1 drugs showed ...
Bank of America 2026 Global Technology Conference June 2, 2026 5:00 PM EDTCompany ParticipantsJennifer Tejada - Executive Chair of ...
Jefferies Global Healthcare Conference 2026 June 3, 2026 11:40 AM EDTCompany ParticipantsHesham Abdullah - Senior VP and Global Head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results